These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3528089)

  • 21. Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status.
    Evans SM; Jenkins WT; Shapiro M; Koch CJ
    Adv Exp Med Biol; 1997; 411():215-25. PubMed ID: 9269430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is misonidazole binding to mouse tissues a measure of cellular pO2?
    Van Os-Corby DJ; Koch CJ; Chapman JD
    Biochem Pharmacol; 1987 Oct; 36(20):3487-94. PubMed ID: 3675609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo.
    Grau C; Bentzen SM; Overgaard J
    Br J Cancer; 1990 Jan; 61(1):61-4. PubMed ID: 2297491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial hypoxia as a cause of radioresistance in a human tumor xenograft: its influence illustrated by the sensitizing effect of misonidazole and hyperbaric oxygen.
    Reynaud-Bougnoux A; Lespinasse F; Malaise EP; Guichard M
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1283-6. PubMed ID: 3759547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced misonidazole binding in the presence of AF-2.
    Olive PL
    Radiat Res; 1987 Mar; 109(3):490-9. PubMed ID: 3562787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent advances in hypoxic cell radiosensitizer].
    Ono K; Takahashi M; Nishidai T; Shibamoto Y; Abe M
    Gan No Rinsho; 1983 Oct; 29(13):1608-12. PubMed ID: 6230470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic binding of misonidazole to mouse tissues. Comparison between labels on the ring and side chain, and the production of tritiated water.
    Franko AJ; Raleigh JA; Sutherland RG; Soderlind KJ
    Biochem Pharmacol; 1989 Feb; 38(4):665-70. PubMed ID: 2917021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of 3H-misonidazole binding between CHO and 9L cells using the sandwich system.
    Hlatky L; Ring C; Sachs RK
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):943-7. PubMed ID: 2703402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo 19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumors.
    Procissi D; Claus F; Burgman P; Koziorowski J; Chapman JD; Thakur SB; Matei C; Ling CC; Koutcher JA
    Clin Cancer Res; 2007 Jun; 13(12):3738-47. PubMed ID: 17575240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of an (iodovinyl)misonidazole derivative for hypoxia imaging.
    Biskupiak JE; Grierson JR; Rasey JS; Martin GV; Krohn KA
    J Med Chem; 1991 Jul; 34(7):2165-8. PubMed ID: 2066990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration.
    Koch CJ; Stobbe CC; Baer KA
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1327-31. PubMed ID: 6469755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Misonidazole chemosensitization of EMT6 spheroids to melphalan.
    Horsman MR; Wood PJ; Brown JM
    Radiother Oncol; 1989 May; 15(1):103-14. PubMed ID: 2748937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro metabolism of misonidazole.
    Josephy PD; Palcic B; Skarsgard LD
    Br J Cancer; 1981 Apr; 43(4):443-50. PubMed ID: 7236487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.
    Taylor YC; Rauth AM
    Br J Cancer; 1980 Jun; 41(6):892-900. PubMed ID: 7426314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of misonidazole to V79 spheroids and fragments of Dunning rat prostatic and human colon carcinomas in vitro: diffusion of oxygen and reactive metabolites.
    Franko AJ; Koch CJ
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1333-6. PubMed ID: 6469756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and characterization of congeners of misonidazole for imaging hypoxia.
    Grunbaum Z; Freauff SJ; Krohn KA; Wilbur DS; Magee S; Rasey JS
    J Nucl Med; 1987 Jan; 28(1):68-75. PubMed ID: 3794812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of misonidazole cytotoxicity by iron.
    Samuni A; Bump EA; Mitchell JB; Brown JM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Jan; 49(1):77-83. PubMed ID: 3079744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of administration schedules on the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by misonidazole in subcutaneous 9L tumors.
    Wong KH; Zhang H; Wallen CA; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1992; 23(4):831-9. PubMed ID: 1618675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
    Mulcahy RT
    Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keynote address: cellular reduction of nitroimidazole drugs: potential for selective chemotherapy and diagnosis of hypoxic cells.
    Chapman JD; Lee J; Meeker BE
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):911-7. PubMed ID: 2649465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.